Gastro-oesophageal Reflux Disease Trial, Recruiting (NCT06693622)

Gastro-oesophageal Reflux Disease Trial, Recruiting NCT06693622 Sponsor: University of Colorado, Denver Condition: Gastro-oesophageal Reflux Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06693622 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Gord

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are able to sign and date a consent form.
People who are willing to follow all study procedures and are available for the whole duration of the study.
People who have 3 or more established risk factors for Barrett's Oesophagus (a condition affecting the food pipe), which include: being over 50 years old, having long-term acid reflux, being male, being white, being a smoker, being obese, or having a family history of Barrett's Oesophagus or a related cancer called oesophageal adenocarcinoma.

Who may not be able to join:

People who are not able to give their own consent to participate.
People who have already been diagnosed with Barrett's Oesophagus or oesophageal adenocarcinoma.
People who have a serious or life-limiting illness or disability.
People who have active dementia or significant difficulties with memory and thinking.
People who are currently incarcerated.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sachin Wani, MD, University of Colorado, Denver

Phone: 303-724-0432

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06693622

Sponsor: University of Colorado, Denver

Phase: Not Applicable

Status: Recruiting

Condition: Gastro-oesophageal Reflux Disease

Trial contact: 303-724-0432

More information: https://clinicaltrials.gov/study/NCT06693622

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are able to sign and date a consent form.
People who are willing to follow all study procedures and are available for the whole duration of the study.
People who have 3 or more established risk factors for Barrett's Oesophagus (a condition affecting the food pipe), which include: being over 50 years old, having long-term acid reflux, being male, being white, being a smoker, being obese, or having a family history of Barrett's Oesophagus or a related cancer called oesophageal adenocarcinoma.

Who may not be able to join:

People who are not able to give their own consent to participate.
People who have already been diagnosed with Barrett's Oesophagus or oesophageal adenocarcinoma.
People who have a serious or life-limiting illness or disability.
People who have active dementia or significant difficulties with memory and thinking.
People who are currently incarcerated.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Colorado, Denver

Registry

ClinicalTrials.gov

Start date

1 November 2024

Est. completion

1 March 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Define patient preferred BE/EAC screening test and barriers for attributes of BE/EAC screening tests

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov